Cost-effectiveness analysis: from science to application
- PMID: 16056009
Cost-effectiveness analysis: from science to application
Abstract
This article proposes ways to improve the credibility and use of cost-effectiveness analysis (CEA) in healthcare decision-making. We argue that the major issue is not the credibility of CEA as a methodology; although there are methodologic challenges, they can be addressed. Two issues, however, will require effort on the part of stakeholders to achieve consensus. First, agreement must be reached regarding the standards of evidence required to support healthcare policy decisions. Second, and of greater importance, the process of healthcare resource allocation decision-making must be viewed as credible and legitimate. We believe that the legitimacy of policy decisions regarding healthcare resource allocation and the acceptance of CEA as a decision tool informing the decision process will require both broad-based stakeholder engagement and transparency throughout the process. For this to occur, stakeholder groups must come to consensus on how to address competing policy goals. Specifically, how should we balance the desires for equity, universal access to healthcare services and technology, and the right of individuals to secure the specific healthcare resources they want?
Similar articles
-
A strategic plan for integrating cost-effectiveness analysis into the US healthcare system.Am J Manag Care. 2008 Apr;14(4):185-8. Am J Manag Care. 2008. PMID: 18402510
-
Generalised cost-effectiveness analysis: an aid to decision making in health.Appl Health Econ Health Policy. 2002;1(2):89-95. Appl Health Econ Health Policy. 2002. PMID: 14619255 Review.
-
Priority setting and the ethics of resource allocation within VA healthcare facilities: results of a survey.Organ Ethic. 2008 Fall-Winter;4(2):83-96. Organ Ethic. 2008. PMID: 18839751
-
Prevention, policy, and paradox: what is the value of future health?Am J Prev Med. 1997 Jan-Feb;13(1):12-7. Am J Prev Med. 1997. PMID: 9037337
-
Pharmacoeconomics.Natl Med J India. 2004 Mar-Apr;17(2):80-3. Natl Med J India. 2004. PMID: 15141600 Review.
Cited by
-
Do economic evaluations of targeted therapy provide support for decision makers?J Oncol Pract. 2011 May;7(3 Suppl):36s-45s. doi: 10.1200/JOP.2011.000315. J Oncol Pract. 2011. PMID: 21886518 Free PMC article.
-
Highlighting the evidence gap: how cost-effective are interventions to improve early childhood nutrition and development?Health Policy Plan. 2015 Jul;30(6):813-21. doi: 10.1093/heapol/czu055. Epub 2014 Jun 23. Health Policy Plan. 2015. PMID: 24963156 Free PMC article. Review.
-
Toward a treaty on safety and cost-effectiveness of pharmaceuticals and medical devices: enhancing an endangered global public good.Global Health. 2006 Mar 28;2:5. doi: 10.1186/1744-8603-2-5. Global Health. 2006. PMID: 16569240 Free PMC article.
-
Do economic evaluations of targeted therapy provide support for decision makers?Am J Manag Care. 2011 May;17 Suppl 5 Developing(0 5 0):SP61-70. Am J Manag Care. 2011. PMID: 21711079 Free PMC article.